Sagent Pharmaceuticals (SGNT) IPO Opens Higher
Tweet Send to a FriendGet Alerts SGNT Hot Sheet
Down)
Trade SGNT Now!
Sagent Pharmaceuticals (Nasdaq: SGNT) IPO is open for trading. Shares are trading at $18.11 after pricing an up-sized offering of 5,750,000 shares at $16, the high end of the expected $14-$16 range.
Morgan Stanley, BofA Merrill Lynch, and Jefferies are acting as the joint bookrunners for the offering.
Sagent Pharmaceuticals, founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Morgan Stanley, BofA Merrill Lynch, and Jefferies are acting as the joint bookrunners for the offering.
Sagent Pharmaceuticals, founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Friday's Hot IPOs Get Even Hotter (MKTO) (DATA)
- UPDATE: Move Inc (MOVE) Higher, Citron Says Long on Twitter
- William Lyon Homes (WLH) IPO Opens 8% Higher
Create E-mail Alert Related Categories
Hot IPOs, IPOs, Trader TalkRelated Entities
Morgan Stanley, Jefferies & Co, Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
